Everence Capital Management’s Krystal Biotech KRYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,060	Closed	-$557K	–	936
2024 Q3	$557K	Buy	+3,060	New	+$557K	0.04%	395